Related Experiment Video
Updated: Dec 24, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Glycoconjugation: An approach to cancer therapeutics
Maria I Molejon1, Gisela Weiz1, Javier D Breccia1
1Institute of Earth and Environmental Sciences from La Pampa (INCITAP), National University of La Pampa, School of Natural Sciences (CONICET-UNLPam), Santa Rosa 6300, La Pampa, Argentina.
Abstract:
Cancer constitutes the second leading cause of death globally and is considered to have been responsible for an estimated 9.6 million fatalities in 2018. Although treatments against gastrointestinal tumors have recently advanced, those interventions can only be applied to a minority of patients at the time of diagnosis. Therefore, new therapeutic options are necessary for advanced stages of the disease. Glycosylation of antitumor agents, has been found to improve pharmacokinetic parameters, reduce side effects, and expand drug half-life in comparison with the parent compounds. In addition, glycosylation of therapeutic agents has been proven to be an effective strategy for their targeting tumor tissue, thereby reducing the doses of the glycodrugs administered to patients. This review focusses on the effect of the targeting properties of glycosylated antitumor agents on gastrointestinal tumors.
Insights
Glycosylation enhances antitumor drugs for gastrointestinal tumors, improving drug delivery and reducing side effects. This review explores how glycosylated drugs target tumors, offering new therapeutic options.
Area of Science:
- Oncology
- Pharmacology
- Drug Delivery
Background:
- Cancer is a leading global cause of death, with limited treatment options for advanced gastrointestinal tumors.
- Current therapies for gastrointestinal tumors are effective only for a small patient subset at diagnosis.
- Novel therapeutic strategies are crucial for managing advanced-stage gastrointestinal cancers.
Purpose of the Study:
- To review the impact of glycosylation on antitumor agents for gastrointestinal tumors.
- To examine the tumor-targeting capabilities of glycosylated drugs.
- To assess the potential of glycosylated antitumor agents in improving treatment outcomes.
Main Methods:
- Literature review of studies on glycosylated antitumor agents.
- Analysis of pharmacokinetic and pharmacodynamic properties of glycodrugs.
- Evaluation of targeting efficiency in gastrointestinal tumor models.
Main Results:
- Glycosylation improves drug pharmacokinetic profiles, including half-life and reduced side effects.
- Glycosylated antitumor agents demonstrate enhanced targeting of gastrointestinal tumor tissues.
- Reduced drug dosages are feasible with glycosylated agents due to improved targeting.
Conclusions:
- Glycosylation is a promising strategy for developing effective antitumor agents against gastrointestinal tumors.
- Targeted delivery of glycosylated drugs offers a potential advantage in cancer therapy.
- Further research into glycosylated antitumor agents could lead to improved patient outcomes.
Related Concept Videos
Protein Glycosylation
Glycosylation occurs in...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

